Ezio Bonvini - Jun 24, 2021 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/28/2021, 08:14 PM
Previous filing
May 18, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $350K +21.9K +26.5% $16.00 104K Jun 24, 2021 Direct
transaction MGNX Common Stock Options Exercise $86.7K +4.22K +4.05% $20.53 109K Jun 24, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee stock option (right to buy) Options Exercise -$350K -21.9K -89.59% $16.00 2.54K Jun 24, 2021 Common Stock 21.9K $16.00 Direct F1
transaction MGNX Employee stock option (right to buy) Options Exercise -$86.7K -4.22K -6.25% $20.53 63.3K Jun 24, 2021 Common Stock 4.22K $20.53 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.